药房托管,这些药企都来抢了!

2018-05-01 半夏 赛柏蓝

药房托管,一个倍受争议的模式,最近又有大突破--官方在文件中鼓励这一模式了!

药房托管,一个倍受争议的模式,最近又有大突破--官方在文件中鼓励这一模式了!

近日,甘肃省食药监局发布《关于推进药品流通企业创新发展的意见》。



《意见》指出,将鼓励药品经营企业兼并重组、支持药品批发企业开展第三方药品物流业务、支持药品批发企业异地设置仓库、支持药品批发企业多仓协作等。

其中,值得重点关注的一点是:“鼓励有条件的药品零售连锁企业参与基层医疗机构“医药分开”、“分级诊疗”进程,承接医院、社区等医疗机构处方外配、药房托管等合作业务”。

据了解,“药房托管”正式成为一个模式,源于2006年5月。当初,在南京市政府和有关主管部门的推动下,南京市150多家二级及以下的医疗机构的药房正式纳入“药房托管”平台。

2011年商务部发布的《全国药品流通行业发展规划纲要(2011~2015年)》中,提出“鼓励连锁药店积极承接医疗机构药房服务和其他专业服务”。随后,“药房托管”在全国范围开始盛行,遍地开花。

但据笔者了解,近年来,对于药房托管国家并没有明确的文件规定,但是各地一直在探索。上述甘肃的做法就是其中之一。

▍药房托管火爆

医院药房托管,和医药SPD供应链管理(即“院内物流延伸”),都是近年来业界的热点话题。

医药SPD供应链管理是指将医院内医疗物资的供应、库存、加工、配送等工作进行集中物流管理服务一体化运行,替代医院传统的物资管理模式,提升医院医疗物资管理效率,提升医院运营现代化水平,降低医疗物资管理成本的一种供应链管理服务。

药房托管则是医疗机构把本应自己履行的药房管理工作以合同的方式委托给他人代为履行,为此签订药房托管协议,受托企业根据合同约定,承担药房管理工作。

从各大上市药企的2017年年报来看,大多数在这两大领域均有涉及。

国药控股

报告期间,国药股份亦通过非公开发行之方式向八名合资格指定投资者按每股认购股份人民币24.90元之发行价发行41,365,452股认购股份,筹集所得款项合共约人民币10.3亿,将在该资产转让交易后主要用作医院供应链延伸项目、社区医院药房托管项目、医院冷链物流系统项目以及信息化建设项目。

上海医药

报告期内,公司提升物流标准化,进一步完善现代医药物流网络,在上海、北京等全国物流中心基础上,推进区域物流中心建设。为维护分销业务的盈利水平,公司持续优化产品结构,推进精益六西格玛管理加强费用控制,并进一步拓展医院供应链创新服务,共托管医院药房226家,新增97家。

截至报告期末,本公司下属品牌连锁零售药房1,892家,其中直营店1,247家。公司与医疗机构院边药房54家,新增14家。同时公司积极参与上海社区综改处方延伸项目,助力分级诊疗,目前已覆盖上海市146家社区医院及卫生服务中心。报告期内实现对接各级医疗机构 214 家,处理超 200 万张电子处方。

康美药业

在全国范围内铺展物流网络建设。公司广泛开展医院收购和药房托管,已签约的医院托管药房已达 100 多家;公司成立健康管理公司,开展健康管理服务和健康产品销售。

华润医药

本集团从客户需求出发,通过对多种创新分销业务模式的推广,进一步加强对下游客户的增值服务能力,截至2017年12月31日,本集团已累计向超过200家医院提供医院物流智慧一体化(「HLI」)服务,并累计实施数十个区域药品智慧化管理(「NHLI」)项目。

华东医药

在现有业务基础上,继续保持向省市大医院提供药事药品物流延伸服务合作,通过项目合作,争取医院资金提前回笼。扩大医院市场销售覆盖,大力开拓民营医院市场份额,做大做深民营医院药品销售业务。继续推进与民营医院药品采购的托管合作模式拓展与药品销售 (物流) 延伸等服务,积极开展药品销售新模式,参与互联网医院药品经营和配送合作。

南京医药

以利益协同的药事服务为核心,公司将继续拓展医疗机构供应链服务业务,持续深化与重点三甲医院的药事服务战略合作,借助信息通讯、云计算、物联网、大数据等技术,打造“互联网+ 药事服务”创新模式,构建以保障药品供应及合理用药为核心的“药事服务”平台和以健康服务为核心的“互联网+健康服务”平台,树立“样板工程”并形成可复制、可推广的实践经验。

以承接医院处方社会化为目标,加快发展自有终端业务,重点打造中医中药模式店、院线店 (院内药房、院边店、DTP 药房等)以及试点多元化门店,各子公司协同开展上述门店模式创新及运营,重点提升社区店盈利能力。同时,以居民健康档案为核心,借助健康管理、慢病管理(结合 PBM 项目)、药学服务等方式推动线上线下协同发展。

九州通

报告期内,公司利用信息技术优势,研究人工智能、区块链等现代信息技术与公司业务结合的可能性,在药品销售的同时,为医疗机构提供信息技术及相关增值服务,通过推进医院药房托管、耗材供应链管理、医院药房物流管理、智能化药库改造和中心药库外延等模式,二级及以上医疗机构业务占公司整体业务的比重不断提升,九州通的销售业务基本覆盖了现有各种类型医药流通和终端应用领域的下游客户。

白云山

本报告期内,本集团及合营企业积极推进现代医药物流延伸服务项目,因应行业政策打造自动化、智能化、信息化的服务体系,不断提升医院现代物流管理能力,同时积极开拓医院中药配送和中药房物流延伸服务,医院服务延伸项目销售较传统医院业务增长明显。

▍医院药房“圈地”大戏

事实上,上述只是部分例子,今年以来,众多药企就已拉开了一场抢占医院药品供应市场的“圈地”大戏。

此前,康美药业接连发布4份公告,从1月31日到2月12日,短短13天内拿下81家医院的药房托管权,涉及广东、吉林和辽宁三省。康美药业表示,这些医院所用的所有药品统一由康美药业负责供应和集中配送,签约期限大多长达15~20年。

可以预见,众多医院的药房,尤其是三甲医院,都将成为药企的“兵家必争之地”,而这其中药企之间的竞争,也将愈演愈烈。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (15)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1691227, encodeId=b143169122ecd, content=<a href='/topic/show?id=8b968e5822e' target=_blank style='color:#2F92EE;'>#药房托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87582, encryptionId=8b968e5822e, topicName=药房托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=270129200363, createdName=陈吴1244, createdTime=Fri Nov 09 00:06:00 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654317, encodeId=d09f165431ed2, content=<a href='/topic/show?id=33248e580a8' target=_blank style='color:#2F92EE;'>#药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87580, encryptionId=33248e580a8, topicName=药房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=878524492877, createdName=sunmin0227, createdTime=Sun Sep 02 22:06:00 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604394, encodeId=11b11604394dc, content=<a href='/topic/show?id=408e5468454' target=_blank style='color:#2F92EE;'>#托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54684, encryptionId=408e5468454, topicName=托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c4f19182763, createdName=spoonycyy, createdTime=Wed May 02 16:06:00 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310984, encodeId=85eb310984c9, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue May 01 12:57:22 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310956, encodeId=c7f9310956a6, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Tue May 01 09:58:28 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310949, encodeId=05eb31094932, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Tue May 01 09:51:33 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310921, encodeId=66da310921db, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue May 01 08:27:38 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310889, encodeId=4cee31088991, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Tue May 01 07:21:56 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310883, encodeId=e7dd310883a5, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Tue May 01 07:17:54 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310869, encodeId=3c8e3108691c, content=利益最大化的机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Tue May 01 06:47:16 CST 2018, time=2018-05-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1691227, encodeId=b143169122ecd, content=<a href='/topic/show?id=8b968e5822e' target=_blank style='color:#2F92EE;'>#药房托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87582, encryptionId=8b968e5822e, topicName=药房托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=270129200363, createdName=陈吴1244, createdTime=Fri Nov 09 00:06:00 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654317, encodeId=d09f165431ed2, content=<a href='/topic/show?id=33248e580a8' target=_blank style='color:#2F92EE;'>#药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87580, encryptionId=33248e580a8, topicName=药房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=878524492877, createdName=sunmin0227, createdTime=Sun Sep 02 22:06:00 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604394, encodeId=11b11604394dc, content=<a href='/topic/show?id=408e5468454' target=_blank style='color:#2F92EE;'>#托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54684, encryptionId=408e5468454, topicName=托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c4f19182763, createdName=spoonycyy, createdTime=Wed May 02 16:06:00 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310984, encodeId=85eb310984c9, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue May 01 12:57:22 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310956, encodeId=c7f9310956a6, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Tue May 01 09:58:28 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310949, encodeId=05eb31094932, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Tue May 01 09:51:33 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310921, encodeId=66da310921db, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue May 01 08:27:38 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310889, encodeId=4cee31088991, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Tue May 01 07:21:56 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310883, encodeId=e7dd310883a5, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Tue May 01 07:17:54 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310869, encodeId=3c8e3108691c, content=利益最大化的机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Tue May 01 06:47:16 CST 2018, time=2018-05-01, status=1, ipAttribution=)]
    2018-09-02 sunmin0227
  3. [GetPortalCommentsPageByObjectIdResponse(id=1691227, encodeId=b143169122ecd, content=<a href='/topic/show?id=8b968e5822e' target=_blank style='color:#2F92EE;'>#药房托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87582, encryptionId=8b968e5822e, topicName=药房托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=270129200363, createdName=陈吴1244, createdTime=Fri Nov 09 00:06:00 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654317, encodeId=d09f165431ed2, content=<a href='/topic/show?id=33248e580a8' target=_blank style='color:#2F92EE;'>#药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87580, encryptionId=33248e580a8, topicName=药房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=878524492877, createdName=sunmin0227, createdTime=Sun Sep 02 22:06:00 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604394, encodeId=11b11604394dc, content=<a href='/topic/show?id=408e5468454' target=_blank style='color:#2F92EE;'>#托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54684, encryptionId=408e5468454, topicName=托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c4f19182763, createdName=spoonycyy, createdTime=Wed May 02 16:06:00 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310984, encodeId=85eb310984c9, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue May 01 12:57:22 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310956, encodeId=c7f9310956a6, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Tue May 01 09:58:28 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310949, encodeId=05eb31094932, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Tue May 01 09:51:33 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310921, encodeId=66da310921db, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue May 01 08:27:38 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310889, encodeId=4cee31088991, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Tue May 01 07:21:56 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310883, encodeId=e7dd310883a5, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Tue May 01 07:17:54 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310869, encodeId=3c8e3108691c, content=利益最大化的机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Tue May 01 06:47:16 CST 2018, time=2018-05-01, status=1, ipAttribution=)]
    2018-05-02 spoonycyy
  4. [GetPortalCommentsPageByObjectIdResponse(id=1691227, encodeId=b143169122ecd, content=<a href='/topic/show?id=8b968e5822e' target=_blank style='color:#2F92EE;'>#药房托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87582, encryptionId=8b968e5822e, topicName=药房托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=270129200363, createdName=陈吴1244, createdTime=Fri Nov 09 00:06:00 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654317, encodeId=d09f165431ed2, content=<a href='/topic/show?id=33248e580a8' target=_blank style='color:#2F92EE;'>#药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87580, encryptionId=33248e580a8, topicName=药房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=878524492877, createdName=sunmin0227, createdTime=Sun Sep 02 22:06:00 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604394, encodeId=11b11604394dc, content=<a href='/topic/show?id=408e5468454' target=_blank style='color:#2F92EE;'>#托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54684, encryptionId=408e5468454, topicName=托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c4f19182763, createdName=spoonycyy, createdTime=Wed May 02 16:06:00 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310984, encodeId=85eb310984c9, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue May 01 12:57:22 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310956, encodeId=c7f9310956a6, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Tue May 01 09:58:28 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310949, encodeId=05eb31094932, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Tue May 01 09:51:33 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310921, encodeId=66da310921db, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue May 01 08:27:38 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310889, encodeId=4cee31088991, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Tue May 01 07:21:56 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310883, encodeId=e7dd310883a5, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Tue May 01 07:17:54 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310869, encodeId=3c8e3108691c, content=利益最大化的机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Tue May 01 06:47:16 CST 2018, time=2018-05-01, status=1, ipAttribution=)]
    2018-05-01 131****1460

    学习了受益匪浅

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1691227, encodeId=b143169122ecd, content=<a href='/topic/show?id=8b968e5822e' target=_blank style='color:#2F92EE;'>#药房托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87582, encryptionId=8b968e5822e, topicName=药房托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=270129200363, createdName=陈吴1244, createdTime=Fri Nov 09 00:06:00 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654317, encodeId=d09f165431ed2, content=<a href='/topic/show?id=33248e580a8' target=_blank style='color:#2F92EE;'>#药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87580, encryptionId=33248e580a8, topicName=药房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=878524492877, createdName=sunmin0227, createdTime=Sun Sep 02 22:06:00 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604394, encodeId=11b11604394dc, content=<a href='/topic/show?id=408e5468454' target=_blank style='color:#2F92EE;'>#托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54684, encryptionId=408e5468454, topicName=托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c4f19182763, createdName=spoonycyy, createdTime=Wed May 02 16:06:00 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310984, encodeId=85eb310984c9, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue May 01 12:57:22 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310956, encodeId=c7f9310956a6, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Tue May 01 09:58:28 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310949, encodeId=05eb31094932, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Tue May 01 09:51:33 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310921, encodeId=66da310921db, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue May 01 08:27:38 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310889, encodeId=4cee31088991, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Tue May 01 07:21:56 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310883, encodeId=e7dd310883a5, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Tue May 01 07:17:54 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310869, encodeId=3c8e3108691c, content=利益最大化的机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Tue May 01 06:47:16 CST 2018, time=2018-05-01, status=1, ipAttribution=)]
    2018-05-01 秀红

    学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1691227, encodeId=b143169122ecd, content=<a href='/topic/show?id=8b968e5822e' target=_blank style='color:#2F92EE;'>#药房托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87582, encryptionId=8b968e5822e, topicName=药房托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=270129200363, createdName=陈吴1244, createdTime=Fri Nov 09 00:06:00 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654317, encodeId=d09f165431ed2, content=<a href='/topic/show?id=33248e580a8' target=_blank style='color:#2F92EE;'>#药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87580, encryptionId=33248e580a8, topicName=药房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=878524492877, createdName=sunmin0227, createdTime=Sun Sep 02 22:06:00 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604394, encodeId=11b11604394dc, content=<a href='/topic/show?id=408e5468454' target=_blank style='color:#2F92EE;'>#托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54684, encryptionId=408e5468454, topicName=托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c4f19182763, createdName=spoonycyy, createdTime=Wed May 02 16:06:00 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310984, encodeId=85eb310984c9, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue May 01 12:57:22 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310956, encodeId=c7f9310956a6, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Tue May 01 09:58:28 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310949, encodeId=05eb31094932, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Tue May 01 09:51:33 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310921, encodeId=66da310921db, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue May 01 08:27:38 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310889, encodeId=4cee31088991, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Tue May 01 07:21:56 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310883, encodeId=e7dd310883a5, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Tue May 01 07:17:54 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310869, encodeId=3c8e3108691c, content=利益最大化的机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Tue May 01 06:47:16 CST 2018, time=2018-05-01, status=1, ipAttribution=)]
    2018-05-01 121832a9m88暂无昵称

    学习了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1691227, encodeId=b143169122ecd, content=<a href='/topic/show?id=8b968e5822e' target=_blank style='color:#2F92EE;'>#药房托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87582, encryptionId=8b968e5822e, topicName=药房托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=270129200363, createdName=陈吴1244, createdTime=Fri Nov 09 00:06:00 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654317, encodeId=d09f165431ed2, content=<a href='/topic/show?id=33248e580a8' target=_blank style='color:#2F92EE;'>#药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87580, encryptionId=33248e580a8, topicName=药房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=878524492877, createdName=sunmin0227, createdTime=Sun Sep 02 22:06:00 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604394, encodeId=11b11604394dc, content=<a href='/topic/show?id=408e5468454' target=_blank style='color:#2F92EE;'>#托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54684, encryptionId=408e5468454, topicName=托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c4f19182763, createdName=spoonycyy, createdTime=Wed May 02 16:06:00 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310984, encodeId=85eb310984c9, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue May 01 12:57:22 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310956, encodeId=c7f9310956a6, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Tue May 01 09:58:28 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310949, encodeId=05eb31094932, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Tue May 01 09:51:33 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310921, encodeId=66da310921db, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue May 01 08:27:38 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310889, encodeId=4cee31088991, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Tue May 01 07:21:56 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310883, encodeId=e7dd310883a5, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Tue May 01 07:17:54 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310869, encodeId=3c8e3108691c, content=利益最大化的机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Tue May 01 06:47:16 CST 2018, time=2018-05-01, status=1, ipAttribution=)]
    2018-05-01 明月清辉

    谢谢分享.学习了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1691227, encodeId=b143169122ecd, content=<a href='/topic/show?id=8b968e5822e' target=_blank style='color:#2F92EE;'>#药房托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87582, encryptionId=8b968e5822e, topicName=药房托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=270129200363, createdName=陈吴1244, createdTime=Fri Nov 09 00:06:00 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654317, encodeId=d09f165431ed2, content=<a href='/topic/show?id=33248e580a8' target=_blank style='color:#2F92EE;'>#药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87580, encryptionId=33248e580a8, topicName=药房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=878524492877, createdName=sunmin0227, createdTime=Sun Sep 02 22:06:00 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604394, encodeId=11b11604394dc, content=<a href='/topic/show?id=408e5468454' target=_blank style='color:#2F92EE;'>#托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54684, encryptionId=408e5468454, topicName=托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c4f19182763, createdName=spoonycyy, createdTime=Wed May 02 16:06:00 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310984, encodeId=85eb310984c9, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue May 01 12:57:22 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310956, encodeId=c7f9310956a6, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Tue May 01 09:58:28 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310949, encodeId=05eb31094932, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Tue May 01 09:51:33 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310921, encodeId=66da310921db, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue May 01 08:27:38 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310889, encodeId=4cee31088991, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Tue May 01 07:21:56 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310883, encodeId=e7dd310883a5, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Tue May 01 07:17:54 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310869, encodeId=3c8e3108691c, content=利益最大化的机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Tue May 01 06:47:16 CST 2018, time=2018-05-01, status=1, ipAttribution=)]
    2018-05-01 wzb521zf

    一起学习学习

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1691227, encodeId=b143169122ecd, content=<a href='/topic/show?id=8b968e5822e' target=_blank style='color:#2F92EE;'>#药房托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87582, encryptionId=8b968e5822e, topicName=药房托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=270129200363, createdName=陈吴1244, createdTime=Fri Nov 09 00:06:00 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654317, encodeId=d09f165431ed2, content=<a href='/topic/show?id=33248e580a8' target=_blank style='color:#2F92EE;'>#药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87580, encryptionId=33248e580a8, topicName=药房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=878524492877, createdName=sunmin0227, createdTime=Sun Sep 02 22:06:00 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604394, encodeId=11b11604394dc, content=<a href='/topic/show?id=408e5468454' target=_blank style='color:#2F92EE;'>#托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54684, encryptionId=408e5468454, topicName=托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c4f19182763, createdName=spoonycyy, createdTime=Wed May 02 16:06:00 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310984, encodeId=85eb310984c9, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue May 01 12:57:22 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310956, encodeId=c7f9310956a6, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Tue May 01 09:58:28 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310949, encodeId=05eb31094932, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Tue May 01 09:51:33 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310921, encodeId=66da310921db, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue May 01 08:27:38 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310889, encodeId=4cee31088991, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Tue May 01 07:21:56 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310883, encodeId=e7dd310883a5, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Tue May 01 07:17:54 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310869, encodeId=3c8e3108691c, content=利益最大化的机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Tue May 01 06:47:16 CST 2018, time=2018-05-01, status=1, ipAttribution=)]
    2018-05-01 龙胆草

    学习谢谢分享

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1691227, encodeId=b143169122ecd, content=<a href='/topic/show?id=8b968e5822e' target=_blank style='color:#2F92EE;'>#药房托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87582, encryptionId=8b968e5822e, topicName=药房托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=270129200363, createdName=陈吴1244, createdTime=Fri Nov 09 00:06:00 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654317, encodeId=d09f165431ed2, content=<a href='/topic/show?id=33248e580a8' target=_blank style='color:#2F92EE;'>#药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87580, encryptionId=33248e580a8, topicName=药房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=878524492877, createdName=sunmin0227, createdTime=Sun Sep 02 22:06:00 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604394, encodeId=11b11604394dc, content=<a href='/topic/show?id=408e5468454' target=_blank style='color:#2F92EE;'>#托管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54684, encryptionId=408e5468454, topicName=托管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c4f19182763, createdName=spoonycyy, createdTime=Wed May 02 16:06:00 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310984, encodeId=85eb310984c9, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue May 01 12:57:22 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310956, encodeId=c7f9310956a6, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Tue May 01 09:58:28 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310949, encodeId=05eb31094932, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Tue May 01 09:51:33 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310921, encodeId=66da310921db, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue May 01 08:27:38 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310889, encodeId=4cee31088991, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Tue May 01 07:21:56 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310883, encodeId=e7dd310883a5, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Tue May 01 07:17:54 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310869, encodeId=3c8e3108691c, content=利益最大化的机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Tue May 01 06:47:16 CST 2018, time=2018-05-01, status=1, ipAttribution=)]
    2018-05-01 易水河

    利益最大化的机会

    0

相关资讯

药房托管后医护收入上涨40%,这个医院咋整的?

导语:医院赚钱了,医护的收入也得到了大幅度提升,是怎么做到的?“医院药房托管后,医护人员收入增加了4成”。据报道,连城县通过公开竞标引入医药企业对县级公立医院药房托管一年来,医护人员年收入平均同比增加40%。备受争议的医院托管,获得如此“成功”,也在医疗界引发热议。医护收入增40%实行药方托管,医院赚钱了,医护的收入也得到了大幅度提升,是怎么做到的?据《医学界》了解,2015年12月底,连城出台《

“药房托管”大整改 广东将出台反垄断执法指南

7月21日,广东发改委发布信息,《药房托管行为反垄断执法指南》开始公开征求意见。

多部门要对药房托管动手

现在,不少药商和公立医院的联姻,大搞“一夫一妻制”——托管。 公立医院姓“公”,人人都有份,凭什么独霸配送权? 眼下,野马狂奔的托管,碰到了硬茬,不是山东。

人大代表谢子龙:药房托管应该紧急叫停

药房托管是随着“医药分开”政策的实施而兴起的一种药房经营方式。理论上讲,药归药,医归医,医院医生从药品中大肆获益的现象将减少,但现实是医院从药品中的获益并未减少,衍生了变相利益输送,还滋生了新的腐败。全国人大代表、老百姓大药房董事长谢子龙两会期间呼吁,国家卫生部门应紧急叫停医院药房托管,因为这是一种损害广大患者利益的方式。

公立医院想要推行药品“零加成” 还需迈过几道槛

药品“零加成”仍是时下热议的医改焦点,本文梳理了相关政策及各方观点,拟较为全面详细地解剖零加成面临的诸多问题。